In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.

Source:http://linkedlifedata.com/resource/pubmed/id/1901332

Download in:

View as

General Info

PMID
1901332